ConjuChem's Unattributed VC Round

ConjuChem raised a round of funding on August 19, 1999.

ConjuChem creates next-generation medicines using unique, long-acting therapeutic peptides. Underlying all ConjuChem compounds are bioconjugation platforms called Drug Affinity Construct (DAC) and Pre…

Articles about ConjuChem's Unattributed VC Round: